WO2016129860A1 - Composition minérale à base de qelby de somatide séparée et extraite à partir d'un minerai naturel - Google Patents

Composition minérale à base de qelby de somatide séparée et extraite à partir d'un minerai naturel Download PDF

Info

Publication number
WO2016129860A1
WO2016129860A1 PCT/KR2016/001223 KR2016001223W WO2016129860A1 WO 2016129860 A1 WO2016129860 A1 WO 2016129860A1 KR 2016001223 W KR2016001223 W KR 2016001223W WO 2016129860 A1 WO2016129860 A1 WO 2016129860A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
mineral
calvi
somatid
composition
Prior art date
Application number
PCT/KR2016/001223
Other languages
English (en)
Korean (ko)
Inventor
이종두
Original Assignee
이종두
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이종두 filed Critical 이종두
Publication of WO2016129860A1 publication Critical patent/WO2016129860A1/fr

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/02—Solvent extraction of solids
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/02—Anti-oxidant compositions; Compositions inhibiting chemical change containing inorganic compounds

Definitions

  • the present invention relates to a mineral somatid composition separated and extracted from an inorganic mineral that is a natural ore. Heat-treatment and aging of ceramic minerals and centrifugation in the presence of water (ionized water) produces gel-based mineral somateides. When the mineral somatide is subjected to a second heat treatment to undergo a drying process, a mineral somatide solidifying material (powder) may be obtained. When the solidified material is pulverized, the solidified material is separated into components of the solidified material and the ceramic inorganic material. More particularly, the present invention relates to a composition of mineral somatid calvi, which contains components, such as SiO 2 , Al 2 O 3 , Fe 2 O 3 , MgO 3 , and K, each independently or all.
  • Somatide which is understood as an intermediate being between matter and life, has been studied by Bechamp, Enderline, Reich, Life, and Ness for over 150 years.
  • microzyma a small microorganism present in human blood
  • Bechamp says that microzyma, a small microorganism present in human blood, is the third component of blood and is the intermediate between life and matter. It is reported to be a cause of fermentation and observed not only in living things but also in the surrounding environment including soil.
  • Japanese Patent Laid-Open No. 2006-166738 (2006.06.29) has been disclosed as a method of obtaining somatid providing a pure function to the human body.
  • This prior patent has a process for making shell fossil into fine particles having a particle size of 0.1 to 5 ⁇ m, mixing with water at a rate of at least 5 cc with respect to 1 g of shell fossil of the fine particles, and holding a mixed solution of the fine particles and water for at least 4 hours. From the mixed acid solution after 4 hours, the precipitate and the supernatant containing calcium carbonate as a main component are separated, and the soot is collected by the method of collecting the ancient somatid, which is characterized in that the soot is an ancient somatid-containing water. Is obtaining.
  • the material for acquiring somatid is limited to ancient shell fossils, and the amount of acquisition is also very small, and may be used for the purpose of simple research, but it may not be used as a material for real life. There is a somewhat difficult problem.
  • the present invention has been made by the above-described background art, and components such as SiO 2 , Al 2 O 3 , Fe 2 O 3 , MgO 3 , K, etc. are each independently contained or all Mineral Somatized Calvi and ceramic minerals extracted from the natural minerals are mixed and eco-friendly organic materials, environmental bio-industrial materials, microbial materials, ceramic materials, food materials, cosmetic materials, anti-cancer, immunity, diabetes, skin treatment It is an object of the present invention to provide a mineral somatid calvi composition used as a pharmaceutical raw material.
  • Mineral Somatized Calvi composition which is separated and extracted from natural ores that are aged and dried, and separated by centrifugation from the dried powder.
  • the mineral Somatized Calvi composition comprises 40 to 60 wt% of SiO2, 18 to 22 wt% of Al2O3, and Fe2O3.
  • the natural ore is 12 to 28% by weight of ocher, 15 to 17% by weight of ganban stone 3 to 5% by weight of jade, 10% to 12% by weight of germanium, 5 wt% to 7 wt% tourmaline, 10 wt% to 13 wt% zeolite, 10 wt% to 12 wt% kaolin, 15 wt% to 17 wt% bentonite, 4 wt% to 5 wt% quartz, or ocher , Sand, jade, elvan, germanium, tourmaline, zeolite, kaolin, bentonite, and crystals each independently provide a natural ore consisting of 100% by weight.
  • the mineral somatid calvi melts the powder made of the natural ore at a temperature of 120 ⁇ 1,000 °C by burning for 1 hour to remove the burned impurities and residual organics from the powder 70-85% by weight of the combusted powder, water, or 15-30% by weight of distilled water are mixed in a stainless steel container or a ceramic container and aged at 1 ° C. to 100 ° C. for 15 days in a sealed state.
  • the powder was dried at a temperature of 180 ° C. for 3 hours, the dried powder was placed in deionized water and centrifuged to obtain a mineral-based somatized supernatant, and the supernatant was dried in a drier of 100 ° C. or higher for 5 hours or more. It provides a mineral somatid calvi composition extracted from natural ores, characterized in that the mineral somatid.
  • the mineral-based somatid calvi extracted from natural ore characterized in that the middle layer is composed of 94 to 99% by weight of ceramic (mineral powder), 1 to 6% by weight of mineral somatid calvi To provide a composition.
  • the mineral somatid calvi provides a mineral somatid calvi composition extracted from natural ores, characterized in that the dried powder is heated at 1000 °C for 1 hour.
  • the natural ore is a component containing SiO 2 , Al 2 O 3 , Fe 2 O 3 , MgO, K, etc., each independently, or two or more or both
  • a mineral somatid calvi composition extracted from a natural ore characterized in that.
  • SiO 2 , Al 2 O 3 , Fe 2 O 3 , MgO 3 , K, etc. are each independently contained, or all of the mineral somatid calvi and ceramic material containing It can be mixed and used as pharmaceutical raw materials such as eco-friendly organic materials, environmental bio-industrial materials, microbial materials, ceramic materials, food materials, cosmetic materials, anti-cancer, immunity, diabetes, and skin treatments. It works.
  • 1 and 2 are taken of the mineral somatid Calvi according to an embodiment of the present invention with 400 times and 1000 times retardation electron microscope, respectively
  • FIG. 3 is a view showing a photograph taken in real time of the mineral somatid Calvi in 400 times using an optical microscope according to an embodiment of the present invention
  • FIG. 4 is a view showing a photograph taken at 800 times the mineral somatized Calvi heated at 1,000 °C for 10 hours according to an embodiment of the present invention using a phase contrast optical microscope.
  • the present invention is 12% to 28% by weight of ocher, 15% to 17% by weight of ganban stone 3% to 5% by weight, 10% to 12% by weight of germanium, 5% to 7% by weight of tourmaline, 10% by weight of zeolite Grinding the natural ore consisting of parts by weight of% to 13% by weight, 10% to 12% by weight of kaolin, 15% to 17% by weight of bentonite, 4% by weight to 5% by weight of quartz, and melted the pulverized powder And heat-treated, aged and dried, and the dried powder is reburned by heating the dried powder at 1000 ° C. for 1 hour, and then separated and extracted from the natural ore separated from the natural ore separated by centrifugation.
  • the mineral somatid Calvi composition is 40 to 60% by weight of SiO2, 18 to 22% by weight of Al2O3, 10 to 14% by weight of Fe2O3, CaO 0.65 to 1.5% by weight, MgO 2.5 to 5% by weight, K2O 2.5 to 7% by weight , Na2O 0.65 to 1.2% by weight, MnO 0.1 to 0.3% by weight, TiO2 0.5 to 0.8% by weight, P2O5 0.1 to 0.2% by weight, balance H2O 5 to 8% by weight It is characterized in that the mineral somatized Calvi composition separated and extracted from the natural ore.
  • the present invention relates to a mineral somatid calvi composition in which a gel-like mineral substance and a ceramic are separated and extracted from natural ores produced in nature.
  • composition of the present invention focused on finding materials that do not burn even under conditions of heating mineral materials extracted from natural ores at a high temperature of 1,000 ° C. for 10 hours.
  • Quantum Energy Living Body: QELBY Quantum Energy Living Body
  • the mineral somatid calvi is composed of SiO 2 , Al 2 O 3 , Fe 2 O 3 , MgO, K, etc. among natural ores including loess, elvan, jade, germanium, tourmaline, zeolite, kaolin, bentonite and quartz. Natural ores, each contained independently, or two or more or both, are used as main raw materials, and can be produced by melting and burning for a predetermined time at a high temperature.
  • the mineral somatid calvi according to the present invention is a metal material containing gold, iron, silver, copper, zinc, stainless steel, titanium, PBT, PET, PE, nylon, epoxy, silicon material containing polymer, cement, carbon, waste It can also be mixed and used with industrial materials, such as ceramic materials, such as a light organic microorganism in fixed ratio.
  • the mineral somatid calvi according to the present invention has its own including cancer cell suppression, immune enhancement, and skin regeneration through the structural change of water (H 2 O ⁇ H 3 O 2 ) in contact and non-contact by the action of reducing radiant energy emitted from mineral substances. It improves heat generation, cold feeling, VOC deodorization, harmful electromagnetic wave shielding absorption, heat dissipation, and can have indoor humidity control and temperature control functions.
  • Mineral Somatid Calvi can produce pharmaceutical, bio and food products used in cancer, diabetes, blood pressure, stroke, AIDS, Parkinson's disease, metabolic diseases, heart disease, organ transplantation.
  • natural ore is 12% to 28% by weight of ocher, 15% to 17% by weight of ganban stone 3% to 5% by weight of jade, 10% to 12% by weight of germanium, 5% to 7% by weight of tourmaline, zeolite 10% to 13% by weight, 10% to 12% by weight of kaolin, 15% to 17% by weight of bentonite, 4% to 5% by weight of quartz, or 100% by weight of each of the natural ores independently
  • the pulverization is made by putting them into a grinder.
  • the ground powder is melted at a temperature of 120 to 1,000 ° C., burned for 1 hour, the burned impurities and residual organics are removed, and the remaining powder is mixed with water or distilled water.
  • the mixing ratio 70 to 85% by weight of the powder, water or 15 to 30% by weight of distilled water are mixed and placed in a stainless steel container or a ceramic container and kept at a temperature of 1 ° C. to 100 ° C. for at least 15 days. After aging, the aging powder is removed from water or distilled water and dried at a temperature of 180 ° C. for at least 3 hours to obtain mineral somatid calvi.
  • the mineral somatid calvi composition according to an embodiment of the present invention is 40 to 60% by weight SiO2, 18 to 22% by weight Al2O3, 10 to 14% by weight Fe2O3, CaO 0.65 to 1.5% by weight, MgO 2.5 to 5% by weight, K2O 2.5 to 7% by weight, Na2O 0.65 to 1.2% by weight, MnO 0.1 to 0.3% by weight, TiO2 0.5 to 0.8% by weight, P2O5 0.1 to 0.2% by weight, the balance H2O 5 to 8% by weight,
  • Figure 1 Is a diagram showing the results of observing the mineral somatized Calvi that has been dried under a phase contrast microscope.
  • the mineral-based somatid calvi prepared according to Example 1 was dissolved in water and observed with a 400x and 800x phase contrast microscope, and thus, a large amount of mineral-based soma showed similar behavior as that of biological somatid.
  • the active movement of the Tid was observed, and in order to confirm the life state of the mineral Somatide Calvi under extreme conditions in which ordinary microorganisms cannot survive, the mineral Somatide Calvi was reheated at 1000 ° C. for 1 hour to burn out the impurities. Observation of the residue left after removal (mineral somatid Calvi), as shown in FIG. 2, showed a mineral somatid calvi that is still active as before heat treatment.
  • the supernatant was separated from the upper, middle and lower layers separated by a centrifuge. This is the result of analyzing the middle layer separately.
  • Mineral somatid Calvi of the present invention will be used in the appropriate content in the manufacture of organic materials, metal materials, polymer materials, microbial materials, mixed materials.
  • the present invention can be used as a pharmaceutical raw materials such as eco-friendly organic materials, environmental bio-industrial materials, microbial materials, ceramic materials, food materials, cosmetic materials, anti-cancer, immunity, diabetes, skin treatments, etc. You can use it.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne : une composition minérale à base d'un corps vivant à énergie quantique (QELBY) de somatide, qui constitue une nouvelle substance antioxydante et multifonctionnelle, séparée et extraite à hauteur d'une concentration élevée à partir d'un minerai naturel ; et un nouveau matériau composite/de fusion de haute technologie l'utilisant. La présente invention peut être utilisée sous la forme d'un matériau métallique, qui est contenu dans un minerai naturel et qui contient respectivement et indépendamment des composants tels que le SiO2, l'Al2O3, le Fe2O3, le MgO3 et le K ou l'ensemble de ces composants ; d'un matériau polymère ; d'un matériau d'agriculture biologique respectueux de l'environnement ; d'un matériau céramique comprenant un matériau utilisable en bioindustrie environnementale ; d'un produit alimentaire ; d'une substance microbienne ; d'une substance cosmétique ; d'un produit pharmaceutique ; d'agents thérapeutiques de fusion/composites anticancéreux, favorisant l'immunité et contre le diabète ; et d'un agent de traitement de la peau ; la présente invention pouvant, de ce fait, être généralement utilisée dans divers domaines industriels.
PCT/KR2016/001223 2015-02-09 2016-02-04 Composition minérale à base de qelby de somatide séparée et extraite à partir d'un minerai naturel WO2016129860A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150019600A KR101559138B1 (ko) 2015-02-09 2015-02-09 천연광석으로부터 분리 추출된 광물계 소마티드 캘비 조성물
KR10-2015-0019600 2015-02-09

Publications (1)

Publication Number Publication Date
WO2016129860A1 true WO2016129860A1 (fr) 2016-08-18

Family

ID=54348401

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/001223 WO2016129860A1 (fr) 2015-02-09 2016-02-04 Composition minérale à base de qelby de somatide séparée et extraite à partir d'un minerai naturel

Country Status (2)

Country Link
KR (1) KR101559138B1 (fr)
WO (1) WO2016129860A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102432010B1 (ko) 2019-10-04 2022-08-16 변재현 소마티드 성분을 포함하는 음식물 숙성 용기의 제조방법 및 이에 의하여 제조된 숙성 용기

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0150870B1 (ko) * 1995-09-23 1998-10-15 조현덕 천연광석분말과 세라믹분말에 미생물을 배양시킨 복합분말
JP2006166738A (ja) * 2004-12-13 2006-06-29 Apatite Corporation:Kk 古代ソマチッドの採取方法及び増殖方法
JP2007297312A (ja) * 2006-04-28 2007-11-15 Daichin Hai 生命機能賦活剤の製造方法
KR101268434B1 (ko) * 2010-04-26 2013-06-04 이종두 규산염 광물을 유효성분으로 포함하는 면역조절 작용을 하는 항암제 및 그 제조 방법
KR101346306B1 (ko) * 2013-06-11 2014-01-02 이종두 광물성 소마티드 추출방법 및 이를 이용한 다기능 첨단 소재 제조방법

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0150870B1 (ko) * 1995-09-23 1998-10-15 조현덕 천연광석분말과 세라믹분말에 미생물을 배양시킨 복합분말
JP2006166738A (ja) * 2004-12-13 2006-06-29 Apatite Corporation:Kk 古代ソマチッドの採取方法及び増殖方法
JP2007297312A (ja) * 2006-04-28 2007-11-15 Daichin Hai 生命機能賦活剤の製造方法
KR101268434B1 (ko) * 2010-04-26 2013-06-04 이종두 규산염 광물을 유효성분으로 포함하는 면역조절 작용을 하는 항암제 및 그 제조 방법
KR101346306B1 (ko) * 2013-06-11 2014-01-02 이종두 광물성 소마티드 추출방법 및 이를 이용한 다기능 첨단 소재 제조방법

Also Published As

Publication number Publication date
KR101559138B1 (ko) 2015-10-13

Similar Documents

Publication Publication Date Title
CN106726628B (zh) 负离子远红外纳米多功能材料
KR101346306B1 (ko) 광물성 소마티드 추출방법 및 이를 이용한 다기능 첨단 소재 제조방법
WO2016129922A1 (fr) Procédé et appareil de traitement de poudre minérale
KR20180079493A (ko) 원적외선 온열효과와 음이온 발생 기능을 갖는 방사체 제조방법 및 이로부터 제조된 방사체
CN106927854A (zh) 一种净化水质的电气石陶瓷球及其制作方法
KR101593108B1 (ko) 천연 광물에 포함된 광물계 소마티드를 이용한 다기능 천연젤 및 천연 파우더 제조방법
WO2016129860A1 (fr) Composition minérale à base de qelby de somatide séparée et extraite à partir d'un minerai naturel
CN109077053A (zh) 一种载银抗菌剂的制备方法
CN105110778A (zh) 啤酒伴侣陶瓷球
RU2526454C1 (ru) Способ получения тонкодисперсного аморфного микрокремнезема
KR101834634B1 (ko) 실리카를 주성분으로 하는 항균조성물질 및 그 조성물질을 이용한 위생용품 제조방법
CN110467445A (zh) 一种石墨烯陶瓷复合滤芯及其制备方法
KR102045616B1 (ko) 상온에서 원적외선을 방사하는 항균비누의 제조방법
KR101102429B1 (ko) 항균성 금속 이온이 교환된 세리사이트 및 이의 제조방법
KR102295706B1 (ko) 항균성 신발깔창의 제조방법 및 이에 의해 제조된 항균성 신발깔창
CN108383472A (zh) 纳米银系功能性陶瓷保健锅
JP2710768B2 (ja) 電気石成形体およびその製造法
WO2011096600A1 (fr) Procédés de préparation de matériau traité à l'argile rouge et eau ionisée alcaline
CN103830966B (zh) 一种强度大耐磨性好的复合陶瓷滤芯及其制备方法
Borisade et al. Investigation of physical, mechanical and in-vitro bioactivity of bioactive glass-ceramics fabricated from waste soda-lime-silica glass doped P2O5 by microwave irradiation sintering
TW201245103A (en) Recycled cement materials and its renewable method of using hazardous industrial waste materials
TWM568839U (zh) Multifunctional natural gel and natural powder container structure
KR20190054433A (ko) 방사능차단 석고보드 제조방법
KR20170030245A (ko) 필로규산염광물을 이용한 천연미네랄 제조방법
Soliman et al. Influence of the addition of different metal oxides on physicochemical and biological properties of calcium fluorosilicate/PCL bone cement

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16749400

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 05.01.208 )

122 Ep: pct application non-entry in european phase

Ref document number: 16749400

Country of ref document: EP

Kind code of ref document: A1